Apyx’s Renuvion Wins NewBeauty Award and Shows Q1 Margin Improvement
Apyx Medical’s Renuvion skin-tightening system secured a NewBeauty Award, highlighting strong clinical adoption and supporting the company’s expansion in the aesthetic device market. The firm also released its Q1 earnings snapshot, reporting improved device shipments, stable gross margins and a narrower operating loss year-over-year.
1. NewBeauty Award Validates Renuvion Growth
Apyx Medical announced that its Renuvion system earned a NewBeauty Award for best skin-tightening device, reinforcing clinical and end-user recognition. This accolade is expected to drive physician interest, accelerate product adoption and support Apyx’s strategy of expanding its aesthetic market share.
2. Q1 Earnings Snapshot Highlights Operational Progress
In its Q1 snapshot, Apyx reported higher device shipment volumes alongside stable gross margins and a reduction in its operating loss compared with the prior year period. Management emphasized controlled operating expenses and growing recurring revenue from consumables as key drivers of improved financial performance.